184 related articles for article (PubMed ID: 19331170)
1. Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis.
Tahara T; Arisawa T; Shibata T; Yamashita H; Yoshioka D; Hirata I
Anticancer Res; 2009 Jan; 29(1):337-41. PubMed ID: 19331170
[TBL] [Abstract][Full Text] [Related]
2. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypomethylation of protease-activated receptor 2 associated with carcinogenesis in the stomach.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Takagi T; Hasegawa S; Wang FY; Hirata I; Nakano H
J Gastroenterol Hepatol; 2007 Jun; 22(6):943-8. PubMed ID: 17517084
[TBL] [Abstract][Full Text] [Related]
4. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
6. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk.
Maekita T; Nakazawa K; Mihara M; Nakajima T; Yanaoka K; Iguchi M; Arii K; Kaneda A; Tsukamoto T; Tatematsu M; Tamura G; Saito D; Sugimura T; Ichinose M; Ushijima T
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):989-95. PubMed ID: 16467114
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas.
Alves MK; Lima VP; Ferrasi AC; Rodrigues MA; De Moura Campos Pardini MI; Rabenhorst SH
APMIS; 2010 Apr; 118(4):297-307. PubMed ID: 20402675
[TBL] [Abstract][Full Text] [Related]
8. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
[TBL] [Abstract][Full Text] [Related]
10. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
11. Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer.
David S; Kan T; Cheng Y; Agarwal R; Jin Z; Mori Y
Biochem Biophys Res Commun; 2009 Jan; 378(3):605-9. PubMed ID: 19046942
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis.
Miyazaki T; Murayama Y; Shinomura Y; Yamamoto T; Watabe K; Tsutsui S; Kiyohara T; Tamura S; Hayashi N
Helicobacter; 2007 Oct; 12(5):523-31. PubMed ID: 17760721
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression.
Gao P; Yang X; Xue YW; Zhang XF; Wang Y; Liu WJ; Wu XJ
Cancer; 2009 Jul; 115(14):3222-32. PubMed ID: 19484794
[TBL] [Abstract][Full Text] [Related]
15. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment.
Tada Y; Wada M; Kuroiwa K; Kinugawa N; Harada T; Nagayama J; Nakagawa M; Naito S; Kuwano M
Clin Cancer Res; 2000 Dec; 6(12):4618-27. PubMed ID: 11156211
[TBL] [Abstract][Full Text] [Related]
16. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach.
Leung WK; Man EP; Yu J; Go MY; To KF; Yamaoka Y; Cheng VY; Ng EK; Sung JJ
Clin Cancer Res; 2006 May; 12(10):3216-21. PubMed ID: 16707623
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of cancer-related genes in gastric carcinoma.
Poplawski T; Tomaszewska K; Galicki M; Morawiec Z; Blasiak J
Exp Oncol; 2008 Jun; 30(2):112-6. PubMed ID: 18566573
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of c-erb-B2 proteins in tumor and non-tumor parts of gastric adenocarcinoma--emphasis on its relation to H. pylori infection and clinicohistological characteristics.
Wang YL; Sheu BS; Yang HB; Lin PW; Chang YC
Hepatogastroenterology; 2002; 49(46):1172-6. PubMed ID: 12143229
[TBL] [Abstract][Full Text] [Related]
19. RANTES promoter genotype and gastric cancer risk in a Japanese population.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Hirata I; Arisawa T
Anticancer Res; 2009 Oct; 29(10):4265-9. PubMed ID: 19846984
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of multidrug resistance 1 gene expression: profiling CpG methylation status using bisulphite sequencing.
Baker EK; El-Osta A
Methods Mol Biol; 2010; 596():183-98. PubMed ID: 19949925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
